Cartesian Growth Corporation IV Class A Ordinary Shares

Aktienanalyse zu Cartesian Growth Corporation IV Class A Ordinary Shares (CGCF)

$9.790

0.000 (0.00%)Zum Schluss

Loading chart…
Hoch
9.790
Eröffnung
9.790
Volumengewichteter Durchschnittskurs
9.78
Volumen
18.63K
Marktkap.
—
Tief
9.770
Umsatz
182.25K
EV/EBITDA, TTM
0.00

Cartesian Growth Corporation IV is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has conducted no operations and has generated no revenue.

KI-Analyse of Cartesian Growth Corporation IV Class A Ordinary Shares (CGCF)

Verkaufen

Cartesian Growth Corp IV (CGCF) is not a good buy right now due to its current price of 9.80, which is close to its 52-week low of 9.78. Additionally, the RSI is at 33.419, indicating that the stock is oversold. The company has reported negative net income for the last two quarters, with losses of -16930.00 USD and -23822.00 USD, which raises concerns about its financial health.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Cartesian Growth Corporation IV Class A Ordinary Shares (CGCF) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .

Erwartetes KGV

5J-Durchschnitt P/E
Aktuelles P/E
0.00

Erwartetes EV/EBITDA

5J-Durchschnitt EV/EBITDA
Aktuelles EV/EBITDA
0.00

Erwartetes KUV

5J-Durchschnitt P/S
Aktuelles P/S
0.00

CGCF FAQ – beantwortet von Alphio AI

Cartesian Growth Corporation IV is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has conducted no operations and has generated no revenue.

Cartesian Growth Corp IV (CGCF) is not a good buy right now due to its current price of 9.80, which is close to its 52-week low of 9.78. Additionally, the RSI is at 33.419, indicating that the stock is oversold. The company has reported negative net income for the last two quarters, with losses of -16930.00 USD and -23822.00 USD, which raises concerns about its financial health.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln